Khushbu R. Prajapati
Ram Shukla
Haresh Vyas
- Consultant and Assistant Professor Department of Panchakarma, Saradar Ayurvedic College and hospital, Mehsana Gujarat India
- Vaidhya Panchakarma Department of Panchakarma, Sarakari Ayurvedic Hospital, Kherva, Mehsana Gujarat India
- Ayurved Practitioner Department of Chikitsa, Ayurveda Chikitsa Mandir and Panchakarma Research Center, Ahmedabad Gujarat India
Abstract
Ulcerative colitis (UC) is a chronic autoimmune disease that causes inflammation and ulcers of the Large intestine. It is one of the most common GI disorder. Usually the pain affects only the intestinal mucosa and sub mucosa, causing small ulcers in the intestinal lining called ulcers. In most of patients, the disease begins from the anus and continues to spread. Its pathogenesis is multi factorial and includes genetic predisposition, epithelial barrier defects, dys regulated immunity, and environmental factors. It can affect the entire intestines. Inflammation causes the intestine to move rapidly and cause discomfort. Bacteria can cause bleeding, discharge of mucus and pus, and symptoms. The aim of medical treatment is firstly to promote rapid treatment and normalize biomarkers and secondly to achieve endoscopic normalization to control the treatment and prevent disability for a long time. Medications such as aminosalicylates, steroids, antibiotics, biological therapy and in severe cases surgery are required.
A 26-year-old woman from Ahmedabad, Gujarat, suffered from sa-ama malapravriti (5 times a day), sa-bala with mala, Bhaya-shoka kale uarah gauravata, niyamita purva apeksha alpa artava slava. Swasanaa Kasthata came to Ayurved Chikitsa Mandir and Panchkarma Research Center in Ahmedabad. So Smriti sagara ras, Udumbaradi leham, Darvi ghrita, grita bhrusta nisha, Tapyadi loha, Loha rasayana, Maha vata vidhvansaka rasa were prescribed. The patient benefited from the colonoscopy in the 7th month of treatment, but her symptoms continued, so medication was started for 2 years and 2 months.
Keywords: Ulcerative colitis, Atisara roga, Ayurveda, Ulcerative Proctitis, CT scan, MRI
References
- Peyrin-Biroulet L, Sandborn W, Sands BE, et al. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): determining therapeutic goals for treat-to-target. Am Gastroenterol. 2015;110:1324–38.
- Jackson B, De Cruz P. Algorithms to facilitate shared decision-making for the management of mild-to-moderate ulcerative colitis. Expert Rev Gastroenterol Hepatol. 2018 Nov;12(11):1079-1100.
- Rubin, D. T., Ananthakrishnan, A. N., Siegel, C. A., Sauer, B. G. & Long, M. D. ACG clinical guideline: ulcerative colitis in adults. J. Gastroenterol.114, 384–413 (2019).
- Yogaratnakara with Hindi “Hindi Commentory by Vaidhya Lakshamipati Sastri Edited by Bhisagratna Bhrahmasankar Sastri ,Chaukhambha Bharati Academy,Purvardha Khanda, 502 p.
- https://ijrap.net/index.php/login/abstractt?id=2511
- Susruta samhita of Maharshi Susruta, Uttarardha Khanda, Edited with ‘Susrutavimarshini “Hindi Commentory alongwith special Deliberation etc. by Dr. Anant Ram Sharma, Varanasi, Chaukhambha Bharati Academy,Uttaratantra, chapter-40, 104-105 306p.
- Grey H. 8 Yoga Poses to Try If You Have Ulcerative Colitis [Internet]. Healthline. Healthline Media; 2022. Available from: https://www.healthline.com/health/ulcerative-colitis/yoga-poses
- Rasa tantra sara and siddha prayoga samgraha, 1nd part written by Thakur Nathusinh ji, published by Krishna gopal Ayurveda Bhavana, 2020,
- Gohel H, Vyas H, Salve R, Purohit S, Italia UV, Sheladiya B. A Case Study on the Ayurvedic Management of Ulcerative Colitis (Grahani). Journal of AYUSH: Ayurveda, Yoga, Unani, Siddha and Homeopathy. 2021;10(1):41-5p.
- Bhaishjyaratnavali of Shri Govind Das with vidhyotini commentary Analysis wih Appendixes by Shri Kaviraja Ambikadatta Shastri Ayurvedacharya, ed Shri Rajeshwadatta Shastri, Chukhambha Sanskrit Sansthana, 26/145-1448.
Journal of AYUSH: Ayurveda, Yoga, Unani, Siddha and Homeopathy
| Volume | |
| Received | December 16, 2023 |
| Accepted | March 14, 2024 |
| Published | April 2, 2024 |